Dapavo, Paolo, Matteo Megna, and Marina Talamonti. 2024. “Efficacy of Tildrakizumab 200 Mg for Treating Difficult-to-Treat Patient Populations With Moderate-to-Severe Plaque Psoriasis”. Dermatology Reports 17 (1). https://doi.org/10.4081/dr.2024.9999.